Borowitz, 1994 - Google Patents
Pathophysiology of gastrointestinal complications of cystic fibrosisBorowitz, 1994
- Document ID
- 8731632376607998493
- Author
- Borowitz D
- Publication year
- Publication venue
- Seminars in respiratory and critical care medicine
External Links
Snippet
The original description of cystic fibrosis (CF) as a distinct entity came in 1938 when Anderson1 recognized that some children with the" celiac syndrome" had pancreatic disease. Recognition of the lung involvement of the disease was secondary. Currently …
- 201000003883 cystic fibrosis 0 title abstract description 102
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Domínguez‐Muñoz | Pancreatic exocrine insufficiency: diagnosis and treatment | |
Balistreri | Neonatal cholestasis | |
Domínguez-Muñoz | Pancreatic enzyme therapy for pancreatic exocrine insufficiency | |
Roy et al. | Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts | |
Malek et al. | Pediatric nephrolithiasis | |
Afghani et al. | An overview of the diagnosis and management of nutrition in chronic pancreatitis | |
Kopel | Gastrointestinal manifestations of cystic fibrosis | |
Apte et al. | Chronic pancreatitis: complications and management | |
di Sant'Agnese et al. | Involvement of abdominal organs in cystic fibrosis of the pancreas | |
Javitt | Cholestasis in infancy: Status report and conceptual approach | |
Nousia-Arvanitakis et al. | Therapeutic approach to pancreatic extract-induced hyperuricosuria in cystic fibrosis | |
Borowitz | Pathophysiology of gastrointestinal complications of cystic fibrosis | |
Milla | Cystic fibrosis: present and future | |
Howard | Extrahepatic biliary atresia: a review of current management | |
Lang et al. | Assessment of exocrine pancreatic function by oral administration of N‐benzoyl‐l‐tyrosyl‐p‐aminobenzoic acid (Bentiromide): 5 years' clinical experience | |
Mascarenhas | Treatment of gastrointestinal problems in cystic fibrosis | |
Albanese | Pediatric surgery | |
Gooding et al. | Gastrointestinal disease in cystic fibrosis | |
Riedel | Gastrointestinal manifestations of cystic fibrosis | |
Edmunds et al. | Alpha 1‐antitrypsin deficiency and pancreatitis in a juvenile | |
Littlewood | Update on intestinal strictures | |
Alagille | Management of chronic cholestasis in childhood | |
Makin et al. | Biliary atresia and other causes of surgical jaundice in infancy | |
Knoll | Consensus Conference on the Management of Cystic Fibrosis: Paris, June 3rd, 1994 | |
Zentler-Munro | Pancreatic exocrine insufficiency and cystic fibrosis |